Metabol KLINIK s.r.o.
- Address
- lock Available on a paid plan
Hormonal Diseases
At Metabol KLINIK s.r.o. the department concentrates on hormonal diseases such as type 2 diabetes and related metabolic conditions. Clinical research seeks to evaluate new therapies that improve glycemic control and lower cardiovascular risk for patients with obesity and diabetes.
- Evaluation of novel glucose‑lowering agents
- Assessment of cardiovascular safety in high‑risk groups
- Investigation of weight‑reduction benefits alongside endocrine outcomes
The site’s two investigators oversee five active studies, integrating endocrine expertise to advance treatment options for patients across Slovakia.
Nutritional and Metabolic Diseases
Research at the clinic also targets nutritional and metabolic diseases, including obesity, overweight and chronic kidney disease. Trials aim to determine the effectiveness of emerging medicines that promote weight loss and protect heart health.
- Efficacy of weight‑management therapies
- Impact on cardiovascular outcomes in metabolic patients
- Safety profiling for individuals with kidney impairment
By linking diet, metabolism, and cardiovascular research, the facility supports innovative approaches to reduce disease burden in the region.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Novo Nordisk A/S1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Eli Lilly & Co.3trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 353 other sites in Slovakia
Therapeutic Area Benchmark — Slovakia
Select a therapeutic area to compare against other sites in Slovakia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Slovakia
Market Share
Country: Slovakia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Metabol KLINIK s.r.o.
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Dose-Finding Study to Evaluate the Efficacy and Safety of Once-Weekly Subcutaneous NNC0662-0419 in Participants with Type 2 Diabetes | Novo Nordisk A/S | Phase II | Recruiting | Apr 2026 | — |
IMP list
lock Showing 1 of 11 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| BI 456906 | 1 | Unknown | 2024-01-08 | 2024-01-08 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.